Skip to main content

Advertisement

SpringerLink
Log in

Modified radical lymphadenectomy (D1.5) for T2–3 gastric cancer

  • Original Article
  • Published:
Langenbeck's Archives of Surgery Aims and scope Submit manuscript

Abstract

Background

The operative mortality in gastric cancer surgery has been reported to be higher with D2 lymphadenectomy than with D1 in the West. The modified radical lymphadenectomy (D1.5) may be safer than D2 under these circumstances. This study was aimed to determine whether D1.5 would deteriorate long-term survival as compared with D2.

Method

Since the concept of the extent of lymphadenectomy varied among the surgeons, 461 patients who underwent curative gastrectomy for T2–4 gastric adenocarcinoma were retrospectively categorized into three groups according to the surgeon: D1 with dissection along the left gastric and common hepatic arteries (D1.5); lymphadenectomy between D1.5 and D2; D2 or more extended dissection.

Results

No differences were found in the survival rates among the three groups within each of the T2a, T2b, and T3 categories. According to a multivariate analysis using Cox’s proportional hazard model, the classification according to the surgeons had no survival impact (p>0.8).

Conclusion

D1.5 lymphadenectomy resulted in a survival rate that was almost equal to that of D2. The use of D1.5 instead of D2 can be an attractive option to be compared with D1 in future trials.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Japanese Research Society for Gastric Cancer (1995) Japanese classification of gastric carcinoma, 1st English edn. Kanehara, Tokyo

    Google Scholar 

  2. Bonenkamp JJ, Hermans J, Sasako M, van de Velde CJ (1999) Extended lymph-node dissection for gastric cancer. Dutch Gastric Cancer Group. N Engl J Med 340:908–914

    PubMed  Google Scholar 

  3. Cuschieri A, Weeden S, Fielding J, Bancewicz J, Craven J, Joypaul V, Sydes M, Fayers P (1999) Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group. Br J Cancer 79:1522–1530

    PubMed  Google Scholar 

  4. Bonenkamp JJ, Songun I, Hermans J, Sasako M, Welvaart K, Plukker JT, van Elk P, Obertop H, Gouma DJ, Taat CW, van Lanschot J, Meyer S, de Graaf PW, von Meyenfeldt MF, Tilanus H, van de Velde CJH (1995) Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet 345:745–748

    PubMed  Google Scholar 

  5. Cuschieri A, Fayers P, Fielding J, Craven J, Bancewicz J, Joypaul V, Cook P (1996) Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. The Surgical Cooperative Group. Lancet 347:995–999

    PubMed  Google Scholar 

  6. Nakajima T (2002) Gastric cancer treatment guidelines in Japan. Gastric Cancer 5:1–5

    Google Scholar 

  7. Sobin LH, Wittekind C (eds) (2002) International Union Against Cancer. TNM classification of malignant tumors, 6th edn. Wiley, New York

  8. de Manzoni G, Verlato G, Guglielmi A, Laterza E, Genna M, Cordiano C (1996) Prognostic significance of lymph node dissection in gastric cancer. Br J Surg 83:1604–1607

    PubMed  Google Scholar 

  9. Roukos DH, Lorenz M, Encke A (1998) Evidence of survival benefit of extended (D2) lymphadenectomy in western patients with gastric cancer based on a new concept: a prospective long-term follow-up study. Surgery 123:573–578

    PubMed  Google Scholar 

  10. Harrison LE, Karpeh MS, Brennan MF (1998) Extended lymphadenectomy is associated with a survival benefit for node-negative gastric cancer. J Gastrointest Surg 2:126–131

    PubMed  Google Scholar 

  11. Onate-Ocana LF, Aiello-Crocifoglio V, Mondragon-Sanchez R, Ruiz-Molina JM (2000) Survival benefit of D2 lymphadenectomy in patients with gastric adenocarcinoma. Ann Surg Oncol 7:210–217

    PubMed  Google Scholar 

  12. Reis E, Kama NA, Doganay M, Atli M, Dolapci M (2002) Long-term survival is improved by an extended lymph node dissection in potentially curable gastric cancer. Hepatogastroenterology 49:1167–1171

    PubMed  Google Scholar 

  13. Sierra A, Regueira FM, Hernandez-Lizoain JL, Pardo F, Martinez-Gonzalez MA, A-Cienfuegos J (2003) Role of the extended lymphadenectomy in gastric cancer surgery: experience in a single institution. Ann Surg Oncol 10:219–226

    PubMed  Google Scholar 

  14. Ramacciato G, Aurello P, D’Angelo F, Cicchini C, Sternberg CN (2000) Does extended lymphadenectomy influence prognosis of gastric carcinoma after curative resection? Hepatogastroenterology 47:1470–1474

    PubMed  Google Scholar 

  15. Volpe CM, Driscoll DL, Douglass HO Jr (2000) Outcome of patients with proximal gastric cancer depends on extent of resection and number of resected lymph nodes. Ann Surg Oncol 7:139–144

    PubMed  Google Scholar 

  16. Bosing NM, Goretzki PE, Roher HD (2000) Gastric cancer: which patients benefit from systematic lymphadenectomy? Eur J Surg Oncol 26:498–505

    PubMed  Google Scholar 

  17. Kasakura Y, Mochizuki F, Wakabayashi K, Kochi M, Fujii M, Takayama T (2002) An evaluation of the effectiveness of extended lymph node dissection in patients with gastric cancer: a retrospective study of 1403 cases at a single institution. J Surg Res 103:252–259

    PubMed  Google Scholar 

  18. Edwards P, Blackshaw GR, Lewis WG, Barry JD, Allison MC, Jones DR (2004) Prospective comparison of D1 vs modified D2 gastrectomy for carcinoma. Br J Cancer 90:1888–1892

    PubMed  Google Scholar 

  19. Siewert JR, Bottcher K, Stein HJ, Roder JD (1998) Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study. Ann Surg 228:449–461

    PubMed  Google Scholar 

  20. Sasako M, McCulloch P, Kinoshita T, Maruyama K (1995) New method to evaluate the therapeutic value of lymph node dissection for gastric cancer. Br J Surg 82:346–351

    PubMed  Google Scholar 

  21. Hartgrink HH, van de Velde CJ, Putter H, Bonenkamp JJ, Klein Kranenbarg E, Songun I, Welvaart K, van Krieken JH, Meijer S, Plukker JT, van Elk PJ, Obertop H, Gouma DJ, van Lanschot JJ, Taat CW, de Graaf PW, von Meyenfeldt MF, Tilanus H, Sasako M (2004) Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol 22:2069–2077

    PubMed  Google Scholar 

  22. Degiuli M, Sasako M, Ponzetto A, Allone T, Soldati T, Calgaro M, Balcet F, Bussone R, Olivieri F, Scaglione D, Danese F, Morino M, Calderini P, Capussotti L, Fronda G, Garavoglia M, Locatelli L, Dellepiane M, Rossini FP, Calvo F (1997) Extended lymph node dissection for gastric cancer: results of a prospective, multi-centre analysis of morbidity and mortality in 118 consecutive cases. Eur J Surg Oncol 23:310–314

    PubMed  Google Scholar 

  23. Giovanetti M, Brotto AC, Tiberio GA, Campedelli L, Vettoretto N, Ronconi M, Di Flumeri G, Giulini SM (1999) D2 lymphectomy in the treatment of gastric cancer: a retrospective view on our experience (1990–1997). J Exp Clin Cancer Res 18:455–458

    PubMed  Google Scholar 

  24. Jatzko GR, Lisborg PH, Denk H, Stettner HM (1999) Stomach carcinoma. Optimizing therapy by extended lymph node dissection. Zentralbl Chir 124:376–380

    PubMed  Google Scholar 

  25. Pugliese R, Maggioni D, Berardi V, Scandroglio I, Pisani D, Mariani A, Di Lernia S, Valli C, Cocotta E (2000) Extended (D2) lymphadenectomy in gastric cancer: a five year experience. Int Surg 85:209–215

    PubMed  Google Scholar 

  26. Roviello F, Marrelli D, Morgagni P, de Manzoni G, Di Leo A, Vindigni C, Saragoni L, Tomezzoli A, Kurihara H (2002) Survival benefit of extended D2 lymphadenectomy in gastric cancer with involvement of second level lymph nodes: a longitudinal multicenter study. Ann Surg Oncol 9:894–900

    PubMed  Google Scholar 

  27. Samson PS, Escovidal LA, Yrastorza SG, Veneracion RG, Nerves MY (2002) Re-study of gastric cancer: analysis of outcome. World J Surg 26:428–433

    PubMed  Google Scholar 

  28. Liu KJ, Atten MJ, Donahue PE, Attar BM (2002) Extended lymphadenectomy for gastric cancer: results in a teaching hospital. Am Surg 68:365–372

    PubMed  Google Scholar 

  29. Sano T, Sasako M, Yamamoto S, Nashimoto A, Kurita A, Hiratsuka M, Tsujinaka T, Kinoshita T, Arai K, Yamamura Y, Okajima K (2004) Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy—Japan Clinical Oncology Group study 9501. J Clin Oncol 22:2767–2773

    PubMed  Google Scholar 

  30. Sasako M (1997) Risk factors for surgical treatment in the Dutch Gastric Cancer Trial. Br J Surg 84:1567–1571

    PubMed  Google Scholar 

  31. Ichikura T, Tomimatsu S, Okusa Y, Mochizuki H (1999) Improved physical condition by limiting lymphadenectomy around the coeliac artery after distal gastrectomy for gastric cancer. Eur J Surg 165:123–132

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery I, National Defense Medical College Hospital, 3-2, Namiki, Tokorozawa, 359-8513, Japan

    Takashi Ichikura, Kentaro Chochi, Hidekazu Sugasawa & Hidetaka Mochizuki

Authors
  1. Takashi Ichikura
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kentaro Chochi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hidekazu Sugasawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hidetaka Mochizuki
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Takashi Ichikura.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ichikura, T., Chochi, K., Sugasawa, H. et al. Modified radical lymphadenectomy (D1.5) for T2–3 gastric cancer. Langenbecks Arch Surg 390, 397–402 (2005). https://doi.org/10.1007/s00423-005-0570-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00423-005-0570-7

Keywords

Search

Navigation